SEC 13F Intelligence

Managers / Q3 2024 · view latest →

Cahill Wealth Management, LLC

CIK 0001927960 · 5831 OAKLAND DRIVE, PORTAGE, MI, 49024 · 269-321-6600

Reported Value
$194M
Q3 2024
Positions
50
Filings on Record
13
2022–present window
Filed
Nov 1, 2024
original filing

Summary

Cahill Wealth Management, LLC reported $194M in U.S.-listed holdings across 50 positions for Q3 2024.

The portfolio is heavily concentrated: IVV alone accounts for 50.3% of reported value.

Compared with Q2 2024, the fund opened 3 new positions and exited 1.

Portfolio Metrics

Turnover
+0.9%
vs prior filed quarter
Top-10 Concentration
+94.9%
share of reported value
Largest Position
+50.3%
Ishares Tr
New / Exited
3 / 1
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q1 ’22: $135MQ1 ’22Q2 ’22: $118MQ3 ’22: $112MQ3 ’22Q4 ’22: $138MQ1 ’23: $135MQ1 ’23Q2 ’23: $145MQ3 ’23: $130MQ3 ’23Q4 ’23: $149MQ1 ’24: $172MQ1 ’24Q2 ’24: $168MQ3 ’24: $194MQ3 ’24Q4 ’24: $196MQ1 ’25: $196MQ1 ’25filingsflow.com

Portfolio Composition

By security type
ETP: 86.1%Common Stock: 13.7%ADR: 0.1%Other: 0.0%
  • ETP · 86.1% · $167M
  • Common Stock · 13.7% · $27M
  • ADR · 0.1% · $222,824
  • Other · 0.0% · $1,261

Quarter-over-Quarter Changes full breakdown →

vs Q2 2024 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
BRK/ABERKSHIRE HATHAWAY INC DELNEW+1717+$12M$12M
WMTWALMART INCNEW+3.1K3.1K+$252,684$252,684
VRNAVERONA PHARMA PLCNEW+7.7K7.7K+$222,824$222,824
BRK/BBERKSHIRE HATHAWAY INC DELADDED+1.6K2.9K+$849,086$1M
XPELXPEL INCSOLD OUT7.5K0$266,913$0
EXPION360 INCTRIMMED20.0K24.4K$43,126$1,261
GOOGLALPHABET INCTRIMMED7081.6K$154,897$257,259
TMDXTRANSMEDICS GROUP INCADDED+7713.5K+$138,369$547,302

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2024

26 positions (from 50 filing rows — )
#IssuerClass% PortfolioValueShares
1IVVISHARES TRCORE S&P500 ETF · CORE S&P SCP ETF · CORE S&P MCP ETF · 20 YR TR BD ETF · CORE US AGGBD ET · EAFE SML CP ETF · RUS 1000 GRW ETF · RUS MD CP GR ETF · CORE MSCI EAFE50.33%$98M417.2K
2DFACDIMENSIONAL ETF TRUSTUS CORE EQUITY 2 · US SMALL CAP VAL · INTL CORE EQT MK · INTL CORE EQUITY · EMERGING MKTS CO · EMGR CRE EQT MNG · US SMALL CAP ETF · US CORE EQT MKT · INTL SMALL CAP E20.44%$40M1.22M
3BRK/ABERKSHIRE HATHAWAY INC DELCL A · CL B NEW6.76%$13M2.9K
4VTIVANGUARD INDEX FDSTOTAL STK MKT · SMALL CP ETF · S&P 500 ETF SHS · MCAP GR IDXVIP · SM CP VAL ETF6.71%$13M46.4K
5BNDVANGUARD BD INDEX FDSTOTAL BND MRKT · INTERMED TERM3.13%$6M79.5K
6AAPLAPPLE INChistory →COM2.30%$4M19.1K
7SPYSPDR S&P 500 ETF TRhistory →TR UNIT1.82%$4M6.2K
8CLPTCLEARPOINT NEURO INChistory →COM1.41%$3M244.4K
9PRFINVESCO EXCHANGE TRADED FD Thistory →FTSE RAFI 10001.04%$2M49.4K
10SPDR SER TRPORTFOLI S&P15000.96%$2M26.7K
11SYKSTRYKER CORPORATIONCOM0.76%$1M4.1K
12SCHBSCHWAB STRATEGIC TRUS BRD MKT ETF0.63%$1M18.4K
13MAMASTERCARD INCORPORATEDCL A0.53%$1M2.1K
14VKTXVIKING THERAPEUTICS INCCOM0.45%$872,41213.8K
15AQSTAQUESTIVE THERAPEUTICS INCCOM0.37%$711,846142.9K
16VCSHVANGUARD SCOTTSDALE FDSSHRT TRM CORP BD · LG-TERM COR BD0.37%$709,2948.9K
17VEUVANGUARD INTL EQUITY INDEX FALLWRLD EX US · FTSE EMR MKT ETF0.36%$699,37812.2K
18VEAVANGUARD TAX-MANAGED FDSVAN FTSE DEV MKT0.35%$684,78813.0K
19AMZNAMAZON COM INCCOM0.33%$633,4063.4K
20TMDXTRANSMEDICS GROUP INCCOM0.28%$547,3023.5K
21ZTSZOETIS INCCL A0.15%$283,7921.5K
22COSTCOSTCO WHSL CORP NEWCOM0.15%$281,095317
23GOOGLALPHABET INCCAP STK CL A0.13%$257,2591.6K
24WMTWALMART INCCOM0.13%$252,6843.1K
25VRNAVERONA PHARMA PLCSPONSORED ADS0.11%$222,8247.7K
26EXPION360 INCCOM0.00%$1,26124.4K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2025$196M49May 12, 202513F-HRchanges · EDGAR ↗
Q4 2024$196M49Feb 13, 202513F-HRchanges · EDGAR ↗
Q3 2024$194M50Nov 1, 202413F-HRchanges · EDGAR ↗
Q2 2024$168M48Aug 13, 202413F-HRchanges · EDGAR ↗
Q1 2024$172M47May 10, 202413F-HRchanges · EDGAR ↗
Q4 2023$149M44Jan 29, 202413F-HRchanges · EDGAR ↗
Q3 2023$130M47Oct 31, 202313F-HRchanges · EDGAR ↗
Q2 2023$145M47Aug 11, 202313F-HRchanges · EDGAR ↗
Q1 2023$135M47May 8, 202313F-HRchanges · EDGAR ↗
Q4 2022$138M47Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$112M41Nov 10, 202213F-HRchanges · EDGAR ↗
Q2 2022$118M41Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$135M41May 10, 202213F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.